Sova, a clinical advisor for Employers Health, expects more employers to exclude GLP-1s for obesity but urges a look at coverage for specific cardiometabolic conditions.
|Articles|July 1, 2004
State structure, consumer focus
Lucinda “Cindy” Ehnes has what she calls “the best job in the healthcare world.” In March, California Governor Arnold Schwarzenegger-appointed Ehnes director of the Department of Managed Health Care (DMHC), an entity unique in the United States because it’s the only state agency whose sole function is managed healthcare and whose structure encompasses the full range of state-level regulatory responsibility.
Advertisement
Advertisement
Related to this article
Employers Health’s Alexis Sova says employers excluding GLP-1s now lean on weight management programs and direct-to-employer deals, not a hard cutoff.
Approximately two-thirds of Employers Health clients now exclude GLP-1s for obesity, up from a roughly even split at launch as cost drives coverage decisions.
Chad Hatfield, Pharm.D., MHA, BCPS, of UC Davis Health, discusses the system's pharmacy shared service center, embedded pharmacists and 340B rebate readiness.
Blood tests reveal early, widespread inflammation in hidradenitis suppurativa, linking biomarkers to disease severity, quality of life, smoking, and potential cardiovascular risk.
UCLA research suggests that GLP-1 therapies may protect bone health in Type 2 diabetes patients.
A study with three years of follow-up shows that the drug stays effective and safe for most, although 16% stopped getting treated with Dupixent, mainly because it was ineffective or caused side effects.
Heart disease became the leading cause of death among Hispanic adults in the U.S. in 2022, and a new American Heart Association statement says risk varies by heritage, with gaps in coverage, language and food access adding to the burden.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Dupixent shows staying power in adolescents and children with atopic dermatitis
2
Large study finds GLP-1 drugs may lower fracture risk in Type 2 diabetes
3
National Alliance names interim head after arrest of its president
4
Systemic inflammation present even in mild hidradenitis suppurativa
5